Literature DB >> 23187860

Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy.

Leng-Yin Wang1, Xuan-Yu Shi, Chung-Shi Yang, Dong-Ming Huang.   

Abstract

Various nanocarriers for photosensitizers have been developed to solve the problems of limiting the clinical utility of photodynamic therapy (PDT); however, to date, no carriers capable of supplying oxygen have been reported. We reported the development of a novel system composed of red blood cell (RBC)-derived vesicles (RDVs) generated by osmotic stress and demonstrated the capacity of RDVs for encapsulating and delivering external cargo into targeted cells due to the cellular uptake of RDVs. In this study, protoporphyrin IX (PpIX)-encapsulated RDVs (PpIX@RDVs) were prepared by the hypotonic incorporation of PpIX into RDVs in an aqueous environment, characterized, and utilized for PDT of cancer. PpIX@RDVs were rapidly uptaken by tumor cells via endocytosis in vitro, and the highly phototoxic effect of PpIX@RDVs was demonstrated upon irradiation. Superoxide anion (O(2)˙) and singlet oxygen ((1)O(2)) were involved in PpIX@RDV-induced cell apoptosis and necrosis. Finally, we demonstrated that RDVs with an oxygen supply capacity have potential as versatile delivery vehicles for efficient PDT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23187860     DOI: 10.1039/c2nr32506c

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  9 in total

1.  Liposome-like Nanostructures for Drug Delivery.

Authors:  Weiwei Gao; Che-Ming J Hu; Ronnie H Fang; Liangfang Zhang
Journal:  J Mater Chem B       Date:  2013-12-28       Impact factor: 6.331

Review 2.  Role of Exosomes for Delivery of Chemotherapeutic Drugs.

Authors:  Aragaw Gebeyehu; Nagavendra Kommineni; David G Meckes; Mandip Singh Sachdeva
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2021       Impact factor: 4.889

Review 3.  Nanotechnology-based cell-mediated delivery systems for cancer therapy and diagnosis.

Authors:  Vahid Alimardani; Zahra Rahiminezhad; Mahvash DehghanKhold; Ghazal Farahavar; Mahboobeh Jafari; Mehdi Abedi; Leila Moradi; Uranous Niroumand; Mohammad Ashfaq; Samira Sadat Abolmaali; Gholamhossein Yousefi
Journal:  Drug Deliv Transl Res       Date:  2022-09-08       Impact factor: 5.671

4.  Nanomedicine-Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy.

Authors:  Jinping Wang; Beilu Zhang; Jingyu Sun; Yuhao Wang; Hongjun Wang
Journal:  Adv Ther (Weinh)       Date:  2019-09-30

5.  Oxygen-Evolving Mesoporous Organosilica Coated Prussian Blue Nanoplatform for Highly Efficient Photodynamic Therapy of Tumors.

Authors:  Zhen Lu Yang; Wei Tian; Qing Wang; Ying Zhao; Yun Lei Zhang; Ying Tian; Yu Xia Tang; Shou Ju Wang; Ying Liu; Qian Qian Ni; Guang Ming Lu; Zhao Gang Teng; Long Jiang Zhang
Journal:  Adv Sci (Weinh)       Date:  2018-02-22       Impact factor: 16.806

Review 6.  Nanomaterials for Tumor Hypoxia Relief to Improve the Efficacy of ROS-Generated Cancer Therapy.

Authors:  Changping Ruan; Kaihua Su; Dongmin Zhao; Ai Lu; Chaoran Zhong
Journal:  Front Chem       Date:  2021-03-19       Impact factor: 5.221

Review 7.  Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives.

Authors:  Arun Butreddy; Nagavendra Kommineni; Narendar Dudhipala
Journal:  Nanomaterials (Basel)       Date:  2021-06-03       Impact factor: 5.076

8.  Biocompatible 5-Aminolevulinic Acid/Au Nanoparticle-Loaded Ethosomal Vesicles for In Vitro Transdermal Synergistic Photodynamic/Photothermal Therapy of Hypertrophic Scars.

Authors:  Zheng Zhang; Yunsheng Chen; Jiayue Ding; Chunlei Zhang; Amin Zhang; Dannong He; Yixin Zhang
Journal:  Nanoscale Res Lett       Date:  2017-12-15       Impact factor: 4.703

9.  pH-Responsive Aerobic Nanoparticles for Effective Photodynamic Therapy.

Authors:  Lingyue Shen; Yu Huang; Dong Chen; Feng Qiu; Chuan Ma; Xin Jin; Xinyuan Zhu; Guoyu Zhou; Zhiyuan Zhang
Journal:  Theranostics       Date:  2017-10-13       Impact factor: 11.556

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.